Replay
10 second
10 second
Annotation
00:00 / 00:00
Pharma companies doing robust business
Indian pharma companies are surging and the numbers prove it by beating the street. Ranbaxy profits rose almost three times at Rs 186 crore as sales of generics in US market surged, revenues were up 23 per cent at Rs 1708 crore. The company has forecasted 15 per cent sales growth for 2007 with a healthy operating profit margin of 16 per cent.
